Bifogade filer
PDF
Beskrivning
| Land | Danmark |
|---|---|
| Lista | Large Cap Copenhagen |
| Sektor | Hälsovård |
| Industri | Läkemedel & Handel |
Valby, Denmark, 9 February 2022 - H. Lundbeck A/S (Lundbeck) hereby publishes and reports transactions made by executives and persons closely associated with them with shares and linked securities in Lundbeck.
+--+-----------------+--------+-----------+
|1.|Details of the |
| |person |
| |discharging |
| |managerial |
| |responsibilities |
| |/ person closely |
| |associated |
+--+-----------------+--------+-----------+
|a)|Name |Deborah Dunsire |
+--+-----------------+--------+-----------+
|2.|Reason for the |
| |notification |
+--+-----------------+--------+-----------+
|a)|Position/status |Chief Executive |
| | |Officer |
+--+-----------------+--------+-----------+
|b)|Initial |Initial notification|
| |notification/Amen| |
| |dment | |
+--+-----------------+--------+-----------+
|3.|Details of the |
| |issuer, |
| |emission |
| |allowance |
| |market |
| |participant, |
| |auction |
| |platform, |
| |auctioneer or |
| |auction monitor |
+--+-----------------+--------+-----------+
|a)|Name |H. Lundbeck A/S |
+--+-----------------+--------+-----------+
|b)|LEI code |5493006R4KC2OI5D3470|
+--+-----------------+--------+-----------+
|4 |Details of the |
| |transaction(s): |
| |section to be |
| |repeated for (i) |
| |each type of |
| |instrument; (ii) |
| |each type of |
| |transaction; |
| |(iii) each date; |
| |and (iv) each |
| |place where |
| |transactions |
| |have been |
| |conducted |
+--+-----------------+--------+-----------+
|a)|Description of |Other (Restricted |
| |the financial |Cash Unit)DK |
| |instrument, type |0010287234 |
| |of instrument | |
| |Identification | |
| |code | |
+--+-----------------+--------+-----------+
|b)|Nature of the |Other transaction |
| |transaction |(vesting of |
| | |Restricted Cash |
| | |Units in accordance |
| | |with long-term |
| | |incentive program. |
| | |Each Restricted Cash|
| | |Unit includes a |
| | |right to receive an |
| | |amount equal to the |
| | |market price of one |
| | |share at time of |
| | |vesting. The vesting|
| | |period is three |
| | |years, and the right|
| | |is subject to |
| | |certain vesting |
| | |criteria being met) |
+--+-----------------+--------+-----------+
|c)|Price(s) and |Price(s)|Volume(s) |
| |volume(s) | | |
+--+-----------------+--------+-----------+
| | |DKK 0 |37,092 |
+--+-----------------+--------+-----------+
|d)|Aggregated | |
| |information | |
| |- Aggregated | |
| |volume | |
| |- Price | |
+--+-----------------+--------+-----------+
|e)|Date of the |2022-02-09 |
| |transaction | |
+--+-----------------+--------+-----------+
|f)|Place of the |Outside a trading |
| |transaction |venue |
+--+-----------------+--------+-----------++--+-----------------+--------+-----------+
|1.|Details of the |
| |person |
| |discharging |
| |managerial |
| |responsibilities |
| |/ person closely |
| |associated |
+--+-----------------+--------+-----------+
|a)|Name |Anders Götzsche |
+--+-----------------+--------+-----------+
|2.|Reason for the |
| |notification |
+--+-----------------+--------+-----------+
|a)|Position/status |Executive Vice |
| | |President & CFO |
+--+-----------------+--------+-----------+
|b)|Initial |Initial notification|
| |notification/Amen| |
| |dment | |
+--+-----------------+--------+-----------+
|3.|Details of the |
| |issuer, |
| |emission |
| |allowance |
| |market |
| |participant, |
| |auction |
| |platform, |
| |auctioneer or |
| |auction monitor |
+--+-----------------+--------+-----------+
|a)|Name |H. Lundbeck A/S |
+--+-----------------+--------+-----------+
|b)|LEI code |5493006R4KC2OI5D3470|
+--+-----------------+--------+-----------+
|4 |Details of the |
| |transaction(s): |
| |section to be |
| |repeated for (i) |
| |each type of |
| |instrument; (ii) |
| |each type of |
| |transaction; |
| |(iii) each date; |
| |and (iv) each |
| |place where |
| |transactions |
| |have been |
| |conducted |
+--+-----------------+--------+-----------+
|a)|Description of |SharesDK 0010287234 |
| |the financial | |
| |instrument, type | |
| |of instrument | |
| |Identification | |
| |code | |
+--+-----------------+--------+-----------+
|b)|Nature of the |Other transaction |
| |transaction |(vesting of |
| | |Restricted Shares in|
| | |accordance with long|
| | |-term incentive |
| | |program) |
+--+-----------------+--------+-----------+
|c)|Price(s) and |Price(s)|Volume(s) |
| |volume(s) | | |
+--+-----------------+--------+-----------+
| | |DKK 0 |14,597 |
+--+-----------------+--------+-----------+
|d)|Aggregated | |
| |information | |
| |- Aggregated | |
| |volume | |
| |- Price | |
+--+-----------------+--------+-----------+
|e)|Date of the |2022-02-09 |
| |transaction | |
+--+-----------------+--------+-----------+
|f)|Place of the |NASDAQ Copenhagen |
| |transaction |XCSE |
+--+-----------------+--------+-----------++--+-----------------+--------+-----------+
|1.|Details of the |
| |person |
| |discharging |
| |managerial |
| |responsibilities |
| |/ person closely |
| |associated |
+--+-----------------+--------+-----------+
|a)|Name |Johan Luthman |
+--+-----------------+--------+-----------+
|2.|Reason for the |
| |notification |
+--+-----------------+--------+-----------+
|a)|Position/status |Executive Vice |
| | |President, Research |
| | |& Development |
+--+-----------------+--------+-----------+
|b)|Initial |Initial notification|
| |notification/Amen| |
| |dment | |
+--+-----------------+--------+-----------+
|3.|Details of the |
| |issuer, |
| |emission |
| |allowance |
| |market |
| |participant, |
| |auction |
| |platform, |
| |auctioneer or |
| |auction monitor |
+--+-----------------+--------+-----------+
|a)|Name |H. Lundbeck A/S |
+--+-----------------+--------+-----------+
|b)|LEI code |5493006R4KC2OI5D3470|
+--+-----------------+--------+-----------+
|4 |Details of the |
| |transaction(s): |
| |section to be |
| |repeated for (i) |
| |each type of |
| |instrument; (ii) |
| |each type of |
| |transaction; |
| |(iii) each date; |
| |and (iv) each |
| |place where |
| |transactions |
| |have been |
| |conducted |
+--+-----------------+--------+-----------+
|a)|Description of |SharesDK 0010287234 |
| |the financial | |
| |instrument, type | |
| |of instrument | |
| |Identification | |
| |code | |
+--+-----------------+--------+-----------+
|b)|Nature of the |Other transaction |
| |transaction |(vesting of |
| | |Restricted Shares in|
| | |accordance with long|
| | |-term incentive |
| | |program) |
+--+-----------------+--------+-----------+
|c)|Price(s) and |Price(s)|Volume(s) |
| |volume(s) | | |
+--+-----------------+--------+-----------+
| | |DKK 0 |6,456 |
+--+-----------------+--------+-----------+
|d)|Aggregated | |
| |information | |
| |- Aggregated | |
| |volume | |
| |- Price | |
+--+-----------------+--------+-----------+
|e)|Date of the |2022-02-09 |
| |transaction | |
+--+-----------------+--------+-----------+
|f)|Place of the |NASDAQ Copenhagen |
| |transaction |XCSE |
+--+-----------------+--------+-----------++--+-----------------+--------+-----------+
|1.|Details of the |
| |person |
| |discharging |
| |managerial |
| |responsibilities |
| |/ person closely |
| |associated |
+--+-----------------+--------+-----------+
|a)|Name |Jacob Tolstrup |
+--+-----------------+--------+-----------+
|2.|Reason for the |
| |notification |
+--+-----------------+--------+-----------+
|a)|Position/status |Executive Vice |
| | |President, |
| | |Commercial |
| | |Operations |
+--+-----------------+--------+-----------+
|b)|Initial |Initial notification|
| |notification/Amen| |
| |dment | |
+--+-----------------+--------+-----------+
|3.|Details of the |
| |issuer, |
| |emission |
| |allowance |
| |market |
| |participant, |
| |auction |
| |platform, |
| |auctioneer or |
| |auction monitor |
+--+-----------------+--------+-----------+
|a)|Name |H. Lundbeck A/S |
+--+-----------------+--------+-----------+
|b)|LEI code |5493006R4KC2OI5D3470|
+--+-----------------+--------+-----------+
|4 |Details of the |
| |transaction(s): |
| |section to be |
| |repeated for (i) |
| |each type of |
| |instrument; (ii) |
| |each type of |
| |transaction; |
| |(iii) each date; |
| |and (iv) each |
| |place where |
| |transactions |
| |have been |
| |conducted |
+--+-----------------+--------+-----------+
|a)|Description of |SharesDK 0010287234 |
| |the financial | |
| |instrument, type | |
| |of instrument | |
| |Identification | |
| |code | |
+--+-----------------+--------+-----------+
|b)|Nature of the |Other transaction |
| |transaction |(vesting of |
| | |Restricted Shares in|
| | |accordance with long|
| | |-term incentive |
| | |program) |
+--+-----------------+--------+-----------+
|c)|Price(s) and |Price(s)|Volume(s) |
| |volume(s) | | |
+--+-----------------+--------+-----------+
| | |DKK 0 |12,282 |
+--+-----------------+--------+-----------+
|d)|Aggregated | |
| |information | |
| |- Aggregated | |
| |volume | |
| |- Price | |
+--+-----------------+--------+-----------+
|e)|Date of the |2022-02-09 |
| |transaction | |
+--+-----------------+--------+-----------+
|f)|Place of the |NASDAQ Copenhagen |
| |transaction |XCSE |
+--+-----------------+--------+-----------++--+-----------------+--------+-----------+
|1.|Details of the |
| |person |
| |discharging |
| |managerial |
| |responsibilities |
| |/ person closely |
| |associated |
+--+-----------------+--------+-----------+
|a)|Name |Keld Flintholm |
| | |Jørgensen |
+--+-----------------+--------+-----------+
|2.|Reason for the |
| |notification |
+--+-----------------+--------+-----------+
|a)|Position/status |Executive Vice |
| | |President, Corporate|
| | |Strategy & Business |
| | |Development |
+--+-----------------+--------+-----------+
|b)|Initial |Initial notification|
| |notification/Amen| |
| |dment | |
+--+-----------------+--------+-----------+
|3.|Details of the |
| |issuer, |
| |emission |
| |allowance |
| |market |
| |participant, |
| |auction |
| |platform, |
| |auctioneer or |
| |auction monitor |
+--+-----------------+--------+-----------+
|a)|Name |H. Lundbeck A/S |
+--+-----------------+--------+-----------+
|b)|LEI code |5493006R4KC2OI5D3470|
+--+-----------------+--------+-----------+
|4 |Details of the |
| |transaction(s): |
| |section to be |
| |repeated for (i) |
| |each type of |
| |instrument; (ii) |
| |each type of |
| |transaction; |
| |(iii) each date; |
| |and (iv) each |
| |place where |
| |transactions |
| |have been |
| |conducted |
+--+-----------------+--------+-----------+
|a)|Description of |SharesDK 0010287234 |
| |the financial | |
| |instrument, type | |
| |of instrument | |
| |Identification | |
| |code | |
+--+-----------------+--------+-----------+
|b)|Nature of the |Other transaction |
| |transaction |(vesting of |
| | |Restricted Shares in|
| | |accordance with long|
| | |-term incentive |
| | |program) |
+--+-----------------+--------+-----------+
|c)|Price(s) and |Price(s)|Volume(s) |
| |volume(s) | | |
+--+-----------------+--------+-----------+
| | |DKK 0 |4,886 |
+--+-----------------+--------+-----------+
|d)|Aggregated | |
| |information | |
| |- Aggregated | |
| |volume | |
| |- Price | |
+--+-----------------+--------+-----------+
|e)|Date of the |2022-02-09 |
| |transaction | |
+--+-----------------+--------+-----------+
|f)|Place of the |NASDAQ Copenhagen |
| |transaction |XCSE |
+--+-----------------+--------+-----------++--+-----------------+--------+-----------+
|1.|Details of the |
| |person |
| |discharging |
| |managerial |
| |responsibilities |
| |/ person closely |
| |associated |
+--+-----------------+--------+-----------+
|a)|Name |Lars Bang |
+--+-----------------+--------+-----------+
|2.|Reason for the |
| |notification |
+--+-----------------+--------+-----------+
|a)|Position/status |Executive Vice |
| | |President, Product |
| | |Development & Supply|
+--+-----------------+--------+-----------+
|b)|Initial |Initial notification|
| |notification/Amen| |
| |dment | |
+--+-----------------+--------+-----------+
|3.|Details of the |
| |issuer, |
| |emission |
| |allowance |
| |market |
| |participant, |
| |auction |
| |platform, |
| |auctioneer or |
| |auction monitor |
+--+-----------------+--------+-----------+
|a)|Name |H. Lundbeck A/S |
+--+-----------------+--------+-----------+
|b)|LEI code |5493006R4KC2OI5D3470|
+--+-----------------+--------+-----------+
|4 |Details of the |
| |transaction(s): |
| |section to be |
| |repeated for (i) |
| |each type of |
| |instrument; (ii) |
| |each type of |
| |transaction; |
| |(iii) each date; |
| |and (iv) each |
| |place where |
| |transactions |
| |have been |
| |conducted |
+--+-----------------+--------+-----------+
|a)|Description of |SharesDK 0010287234 |
| |the financial | |
| |instrument, type | |
| |of instrument | |
| |Identification | |
| |code | |
+--+-----------------+--------+-----------+
|b)|Nature of the |Other transaction |
| |transaction |(vesting of |
| | |Restricted Shares in|
| | |accordance with long|
| | |-term incentive |
| | |program) |
+--+-----------------+--------+-----------+
|c)|Price(s) and |Price(s)|Volume(s) |
| |volume(s) | | |
+--+-----------------+--------+-----------+
| | |DKK 0 |12,797 |
+--+-----------------+--------+-----------+
|d)|Aggregated | |
| |information | |
| |- Aggregated | |
| |volume | |
| |- Price | |
+--+-----------------+--------+-----------+
|e)|Date of the |2022-02-09 |
| |transaction | |
+--+-----------------+--------+-----------+
|f)|Place of the |NASDAQ Copenhagen |
| |transaction |XCSE |
+--+-----------------+--------+-----------+Persons under an obligation to report are defined as members of the Executive Management, members of the Board of Directors and other executives of H. Lundbeck A/S and persons/entities closely associated to them.
Closely associated persons/entities means inter alia:
- spouse or cohabitant
- dependent children
- legal entities in which the executive has a controlling influence.
Lundbeck contacts
Investors: Media:
Palle Holm Olesen Juliane Lenzner
Vice President, Investor Relations Vice President,
Corporate
Communication
PALO@lundbeck.com JULZ@lundbeck.com
+45 30 83 24 26 +45 36 43 40 00
About H. Lundbeck A/S
H. Lundbeck A/S (LUN.CO, LUN DC, HLUYY) is a global pharmaceutical company specialized in brain diseases. For more than 70 years, we have been at the forefront of neuroscience research. We are tirelessly dedicated to restoring brain health, so every person can be their best.
An estimated 700 million people worldwide are living with brain diseases and far too many suffer due to inadequate treatment, discrimination, a reduced number of working days, early retirement and other unnecessary consequences. Every day, we strive for improved treatment and a better life for people living with brain diseases - we call this Progress in Mind.
Read more at www.lundbeck.com/global/about-us/progress-in-mind (https://webmaster.lundbeck.com/N2/Content/wwww.lundbeck.com/global/about-us/progress-in-mind).
For additional information, we encourage you to visit our corporate site www.lundbeck.com and connect with us on Twitter at @Lundbeck andvia LinkedIn.